🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lenalidomide has clinical activity in myeloma. The closely related compound...
Status
Completed
Location
Yale University
Start Date
2011-06
Trial ID
NCT01319422
Treatments Being Tested
Doctors leading this study hope to learn if the combination of belantamab m...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2023-05-30
Trial ID
NCT05789303
Treatments Being Tested
The purpose of this clinical trial is to examine the role of an immune modu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04584307
Treatments Being Tested
This multicenter trial evaluates the efficacy and safety of pomalidomide co...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-08-01
Trial ID
NCT07257510
Treatments Being Tested
This is a randomized phase II open label study of daratumumab, weekly low-d...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2017-10-25
Trial ID
NCT03215524
Study a quadruplet-based regimen with Minimal Residual Disease (MRD) 10-5 n...
Status
Unknown
Location
CHU Poitiers
Start Date
2020-08-28
Trial ID
NCT04287855
Treatments Being Tested
The purpose of the study is to determine the maximum tolerated dose, safety...
Status
Completed
Location
Karmanos Cancer Institute
Start Date
2007-08-01
Trial ID
NCT01522547
Treatments Being Tested
To investigate the safety and efficacy of the ATRA combined with the KPD re...
Status
Recruiting
Location
Bing Xu
Start Date
2023-11-22
Trial ID
NCT06158412
Treatments Being Tested
This trial will evaluate the efficacy and safety of combination of pomalido...
Status
Completed
Location
Local Institution - 126
Start Date
2014-05-29
Trial ID
NCT01946477
Treatments Being Tested
This is an open-label, multicentre, dose escalation study to characterize t...
Status
Completed
Location
AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I
Start Date
2011-07
Trial ID
NCT01421186
Treatments Being Tested